Obstetrics & Gynaecology

AMC Gynaecology MCQs

This page covers the general gynaecology the AMC MCQ exam tests, from abnormal uterine bleeding and pelvic pain to PCOS, amenorrhoea, infertility, menopause, prolapse, incontinence and acute adnexal problems. It is built on Australian guidance, including the Heavy Menstrual Bleeding Clinical Care Standard, the Australian endometriosis guideline and the 2023 international PCOS guideline led from Australia.

Most tested
Heavy menstrual bleeding work-up, endometriosis, PCOS, secondary amenorrhoea, MHT, ovarian torsion
Guideline to know
ACSQHC Heavy Menstrual Bleeding Clinical Care Standard; RANZCOG Australian Endometriosis Guideline
Classic trap
Reassuring normal Doppler flow in suspected ovarian torsion
Study time
12–14 hours

What the AMC tests in gynaecology

Gynaecology questions are mostly set in general practice, with a few in the emergency department. The patient is a teenager with painful periods, a woman in her thirties with heavy bleeding or difficulty conceiving, or a woman in her fifties with flushes or leaking urine. The exam tests whether you can take the right first steps in primary care, choose the correct investigation, offer evidence-based first-line treatment and know when to refer.

Two habits help. First, always check for pregnancy in a woman of reproductive age with bleeding, pain or amenorrhoea; the AMC often places a positive hCG in a stem about something else. Second, think of age-related risk: the same bleeding pattern means something different at 25 and at 50, mainly because of endometrial cancer risk.

  • Lead-ins: first investigation, most likely diagnosis, first-line treatment, when to refer
  • First test in almost every stem: pregnancy test
  • Postmenopausal bleeding is covered on the gynaecological cancer page; it is never normal

Abnormal uterine bleeding, dysmenorrhoea, fibroids and adenomyosis

Abnormal uterine bleeding is classified using PALM-COEIN: structural causes (polyp, adenomyosis, leiomyoma, malignancy or hyperplasia) and non-structural causes (coagulopathy, ovulatory dysfunction, endometrial, iatrogenic, not yet classified). The ACSQHC Heavy Menstrual Bleeding Clinical Care Standard sets Australian expectations: take a focused history including the impact on quality of life, check for iron deficiency, use pelvic ultrasound (preferably transvaginal) as first-line imaging when a structural cause is suspected, offer effective medical treatment before surgery, and use hysteroscopy with directed biopsy rather than blind curettage when the endometrium needs assessment.

Medical options for heavy menstrual bleeding include the levonorgestrel intrauterine device (the most effective medical option for many women), tranexamic acid during menses, NSAIDs such as mefenamic acid, combined hormonal contraception and oral progestogens. Endometrial assessment is needed for women with risk factors for hyperplasia: age around 45 or more with persistent bleeding, obesity, PCOS with long anovulatory cycles, tamoxifen use, failed medical treatment or intermenstrual bleeding.

Primary dysmenorrhoea starts soon after menarche and has no pelvic pathology; NSAIDs from the start of bleeding and hormonal contraception are first line. Secondary dysmenorrhoea suggests endometriosis, adenomyosis, fibroids or pelvic infection. Fibroids cause heavy bleeding, pressure symptoms and sometimes subfertility; treatment depends on symptoms, size, location and fertility wishes, ranging from medical treatment to myomectomy, uterine artery embolisation or hysterectomy. Adenomyosis typically causes heavy painful periods with a bulky, tender uterus in a parous woman and is seen on ultrasound or MRI.

  • Heavy bleeding: FBC and ferritin; treat iron deficiency
  • First-line imaging: transvaginal ultrasound
  • Endometrial sampling: hysteroscopy and directed biopsy for women at risk
  • LNG-IUD: effective first-line medical option, also contraceptive
  • Fibroid pain in pregnancy: red degeneration; analgesia and supportive care

Endometriosis and polycystic ovary syndrome

Endometriosis causes cyclical pelvic pain, deep dyspareunia, painful bowel or bladder symptoms around menses and subfertility. Diagnosis is often delayed for years. The Australian endometriosis guideline supports starting treatment on clinical suspicion: a laparoscopy is not required before trying first-line medical therapy. Transvaginal ultrasound by an experienced sonographer can detect endometriomas and deep disease. First-line treatment is analgesia (NSAIDs) and hormonal suppression, such as continuous combined hormonal contraception, progestogens (including dienogest) or the LNG-IUD. Laparoscopy is used when the diagnosis is uncertain, medical therapy fails, there is an endometrioma or infertility, and excision allows histological confirmation.

PCOS is diagnosed in adults using the Rotterdam criteria: two of ovulatory dysfunction, clinical or biochemical hyperandrogenism, and polycystic ovarian morphology on ultrasound or a raised AMH, after excluding other causes (thyroid disease, raised prolactin, non-classic congenital adrenal hyperplasia). The 2023 international guideline, led from Monash University, advises that in adolescents both ovulatory dysfunction and hyperandrogenism are needed, and ultrasound or AMH should not be used within eight years of menarche.

PCOS management targets the woman's priorities. Lifestyle support and weight-neutral health advice come first. Combined hormonal contraception treats irregular cycles and hirsutism and protects the endometrium. Metformin helps metabolic features. For ovulation induction in infertility, letrozole is first line. Screening for cardiometabolic risk (glucose tolerance, lipids, blood pressure), mood disorders and sleep apnoea is part of long-term care.

  • Endometriosis: treat empirically; laparoscopy is not required first
  • Endometrioma ('chocolate cyst') on ultrasound: gynaecology referral
  • PCOS adults: two of three Rotterdam criteria after excluding mimics
  • PCOS adolescents: no ultrasound or AMH within 8 years of menarche
  • PCOS infertility: letrozole is first-line ovulation induction
  • Long anovulatory cycles in PCOS: protect the endometrium with a progestogen or COC

Amenorrhoea and infertility work-up

Primary amenorrhoea is no periods by age 15 with normal secondary sexual characteristics, or by 13 with none. Secondary amenorrhoea is no period for three months in a woman with previously regular cycles, or six months with irregular cycles. Start with a pregnancy test. Then check FSH, LH, oestradiol, prolactin and TSH, and testosterone if there is hyperandrogenism.

Interpreting results: low or normal FSH and LH with low oestradiol suggests hypothalamic amenorrhoea (low energy availability, excessive exercise, stress, eating disorders), which is common in exam stems about athletes. High FSH on repeat testing in a woman under 40 means premature ovarian insufficiency, which needs hormone therapy until the average age of menopause to protect bone and heart. A high prolactin needs a medication review and pituitary imaging if there is no other cause. Asherman syndrome follows uterine instrumentation such as curettage. Primary amenorrhoea with absent uterus suggests Mullerian agenesis or androgen insensitivity.

Infertility is failure to conceive after 12 months of regular unprotected intercourse, or six months if the woman is 35 or older. Investigate both partners together. For the woman, confirm ovulation with a mid-luteal progesterone, check thyroid and prolactin if cycles are irregular, check rubella immunity and screen for chlamydia, and assess tubal patency (HyCoSy or HSG, or laparoscopy if pelvic disease is suspected). For the man, semen analysis is an early, essential test. Lifestyle advice covers smoking, alcohol, weight and folic acid. Referral to a fertility specialist is earlier for older women, known tubal disease, endometriosis or male factor.

  • Amenorrhoea step one: pregnancy test
  • Athlete with amenorrhoea and low FSH/LH: hypothalamic amenorrhoea; check bone density and energy intake
  • FSH raised on two occasions under 40: premature ovarian insufficiency
  • Infertility: investigate at 12 months, or 6 months if 35 or older
  • Semen analysis early, not after the woman's tests

Menopause, menopausal hormone therapy and premenstrual disorders

Menopause is a clinical diagnosis in women over 45 with typical symptoms and changes in their cycle; FSH testing is not needed in this group. Testing is more useful under 45 or when the picture is unclear. Symptoms include vasomotor symptoms, sleep disturbance, mood change, joint aches and genitourinary symptoms such as vaginal dryness and recurrent urinary infections.

Menopausal hormone therapy (MHT) is the most effective treatment for vasomotor symptoms. For healthy women under 60 or within 10 years of menopause, the benefits generally outweigh the risks. Women with a uterus need a progestogen with oestrogen to protect the endometrium; women after hysterectomy can take oestrogen alone. Transdermal oestrogen carries a lower VTE risk than oral and is preferred if there are VTE risk factors, migraine or obesity. Contraindications include current or past breast cancer, undiagnosed vaginal bleeding, active liver disease and recent VTE or stroke. Vaginal oestrogen for genitourinary symptoms is low-dose and does not need a progestogen. Non-hormonal options for vasomotor symptoms include certain SSRIs or SNRIs, gabapentin and clonidine.

Premenstrual syndrome causes physical and mood symptoms in the luteal phase that resolve with menstruation. Severe mood symptoms with functional impairment meet criteria for premenstrual dysphoric disorder. A symptom diary over two cycles confirms the cyclical pattern. Treatment includes lifestyle measures, SSRIs (continuous or luteal phase) and combined hormonal contraception, particularly continuous regimens.

  • Over 45 with typical symptoms: no FSH test needed
  • Uterus present: oestrogen plus progestogen
  • VTE risk, migraine or obesity: transdermal oestrogen
  • Vaginal oestrogen: no progestogen needed
  • MHT does not provide contraception in perimenopausal women

Prolapse, urinary incontinence, ovarian cysts, torsion and Bartholin abscess

Pelvic organ prolapse causes a dragging sensation or a bulge, sometimes with voiding or bowel symptoms. Options are watchful waiting, pelvic floor muscle training, a vaginal pessary and surgery. Transvaginal mesh for prolapse was removed from the Australian Register of Therapeutic Goods by the TGA in 2018 after reports of serious harm, so it is not a correct answer for an Australian stem. Native tissue repair or, in selected women, abdominal sacrocolpopexy are the surgical options.

For urinary incontinence, separate stress (leakage with cough, sneeze, exercise) from urge (sudden need, frequency, nocturia) and mixed. Check urinalysis to exclude infection and haematuria, and use a bladder diary. Stress incontinence is treated first with supervised pelvic floor muscle training for at least three months, then surgery if needed. Urge incontinence is treated with bladder training, reducing caffeine and fluid adjustment, then antimuscarinics or mirabegron. Antimuscarinics add to anticholinergic burden and can worsen cognition in older women, which is often tested.

Ovarian cysts in premenopausal women are mostly functional and resolve; a small simple cyst can be rescanned in a few months. In postmenopausal women, use ultrasound features, CA-125 and menopausal status to estimate malignancy risk and refer. Ovarian torsion presents with sudden severe unilateral pain, nausea and vomiting, often with an ovarian mass such as a dermoid. Doppler can show normal flow even when torsion is present, so clinical suspicion means urgent laparoscopy to untwist and preserve the ovary. A Bartholin abscess is treated by drainage with a Word catheter or marsupialisation, which reduces recurrence compared with simple incision. A new Bartholin gland mass in a woman over about 40 needs biopsy to exclude cancer.

  • Prolapse first line: pelvic floor training or pessary; no transvaginal mesh in Australia
  • Stress incontinence: pelvic floor training for at least 3 months before surgery
  • Urge incontinence in older women: be cautious with antimuscarinics
  • Suspected torsion: laparoscopy even if Doppler is normal
  • Bartholin abscess: Word catheter or marsupialisation

Australian differences and how to read gynaecology stems

Australian specifics include the Heavy Menstrual Bleeding Clinical Care Standard, the national endometriosis action plan and guideline that support earlier diagnosis and empiric treatment, the 2023 PCOS guideline that changed rules for adolescents and allowed AMH in adults, the Australasian Menopause Society guidance on MHT, and the TGA removal of transvaginal mesh for prolapse. Women's health physiotherapists are a standard part of care for pelvic floor problems.

In stems, start with age and pregnancy status. Then sort the problem: bleeding, pain, cycle disturbance, fertility, menopause or pelvic floor. Choose the investigation that answers the question most directly (pregnancy test, ultrasound, hormone profile), then the least invasive effective treatment. Choose referral when there are red flags: postmenopausal bleeding, a complex mass, suspected torsion, or failure of first-line treatment.

  • Teenager with dysmenorrhoea not settling on NSAIDs and COC: think endometriosis
  • Woman over 45 with heavy irregular bleeding: endometrial assessment
  • Sudden pain with vomiting and adnexal mass: torsion, theatre
  • Older woman with urge incontinence and memory concerns: avoid antimuscarinic as first answer
Gynaecology presentations and first-line responses
PresentationFirst investigationFirst-line management
Heavy menstrual bleeding, age 30FBC, ferritin, pelvic ultrasound if structural cause suspectedLNG-IUD, tranexamic acid, NSAIDs or COC
Heavy irregular bleeding, age 47Transvaginal ultrasoundHysteroscopy and directed biopsy
Primary dysmenorrhoeaClinical diagnosisNSAIDs, hormonal contraception
Suspected endometriosisTransvaginal ultrasoundEmpiric NSAIDs and hormonal suppression
Irregular cycles and hirsutismTestosterone, TSH, prolactin, 17-OH progesterone; ultrasound or AMH in adultsLifestyle, COC; letrozole for fertility
Secondary amenorrhoea in a runnerhCG, FSH, LH, oestradiol, prolactin, TSHRestore energy availability; bone health
Infertility after 12 monthsMid-luteal progesterone, semen analysis, tubal patencyLifestyle, treat cause, specialist referral
Vasomotor symptoms, age 52, uterus presentClinical diagnosisCombined MHT if no contraindication
Stress urinary incontinenceUrinalysis, bladder diarySupervised pelvic floor training 3 months
Sudden pain, vomiting, adnexal massUltrasound if it does not delay careUrgent laparoscopy for torsion

Worked examples in AMC style

Pick an answer to see why each option is right or wrong. These examples are written for this page; the bank holds the full set for gynaecology.

Example 1

A 19-year-old woman presents to the emergency department with sudden severe right iliac fossa pain that began 3 hours ago while playing netball, with repeated vomiting. Urine hCG is negative. She is afebrile. Ultrasound shows a 6 cm right ovarian mass with arterial Doppler flow present.

What is the most appropriate next step?

Show answer and reasoning

Answer: B. Urgent laparoscopy to assess for torsion

  • A. Sudden pain, vomiting and an ovarian mass suggest torsion; discharge risks loss of the ovary.
  • B. Torsion is a clinical diagnosis. Doppler flow can be present in torsion, so urgent laparoscopy to untwist and preserve the ovary is needed.
  • C. Her history is sudden and mechanical with no features of infection.
  • D. CT delays surgery and adds radiation; ultrasound has already shown the likely cause.
  • E. CA-125 is not useful acutely and is often raised by benign conditions in young women.

Suspected ovarian torsion: laparoscopy even when Doppler flow is normal.

Based on: RANZCOG guidance; state gynaecology emergency guidelines

Example 2

A 24-year-old woman has had painful periods since age 16 that now stop her working for two days each month, with deep dyspareunia. NSAIDs give partial relief. She does not want pregnancy now. Pelvic examination is normal and a transvaginal ultrasound by an experienced sonographer is normal.

What is the most appropriate next step?

Show answer and reasoning

Answer: B. Start continuous combined hormonal contraception

  • A. The Australian endometriosis guideline does not require laparoscopy before medical treatment.
  • B. Suspected endometriosis can be treated empirically. Continuous combined hormonal contraception (or a progestogen) with NSAIDs is first line, with review of the response.
  • C. MRI may help in selected cases but is not required before first-line treatment.
  • D. A normal ultrasound does not exclude superficial endometriosis.
  • E. GnRH agonists are second line because of menopausal side effects and bone loss.

Suspected endometriosis: start NSAIDs and hormonal suppression without waiting for laparoscopy.

Based on: RANZCOG Australian Clinical Practice Guideline for the Diagnosis and Management of Endometriosis (2021)

Example 3

A 52-year-old woman has had hot flushes and night sweats for 9 months that disturb her sleep. Her last period was 14 months ago. She has a uterus. She is a non-smoker with a BMI of 33 kg/m2 and a history of migraine without aura. She has no personal or family history of breast cancer or VTE.

What is the most appropriate treatment?

Show answer and reasoning

Answer: D. Transdermal oestrogen plus progestogen

  • A. Unopposed oestrogen causes endometrial hyperplasia in a woman with a uterus.
  • B. Vaginal oestrogen treats genitourinary symptoms, not vasomotor symptoms.
  • C. Oral oestrogen carries higher VTE risk, which matters with her BMI.
  • D. She has a uterus, so she needs a progestogen. Transdermal oestrogen is preferred given obesity and migraine because it has lower VTE risk.
  • E. Migraine without aura is not a contraindication; route choice is the adjustment.

MHT with a uterus needs a progestogen; choose transdermal oestrogen if VTE risk factors or migraine.

Based on: Australasian Menopause Society guidance

Quick recall

Tap a card to turn it over. If you can answer all eight without looking, move on to timed questions.

Where candidates lose marks

  • Trusting Doppler in torsion

    Flow can be normal. Clinical suspicion means laparoscopy.

  • Laparoscopy before endometriosis treatment

    Australian guidance supports empiric treatment first.

  • Unopposed oestrogen

    A woman with a uterus on MHT needs a progestogen.

  • Transvaginal mesh for prolapse

    It was removed from the Australian market and is a wrong answer.

  • Blind D&C for bleeding

    Hysteroscopy with directed biopsy is the Australian standard.

How to study gynaecology

  1. Day 1: Abnormal uterine bleeding using PALM-COEIN and the HMB Clinical Care Standard; fibroids and adenomyosis.

  2. Day 2: Dysmenorrhoea and endometriosis using the Australian guideline; then PCOS using the 2023 international guideline.

  3. Day 3: Primary and secondary amenorrhoea with hormone profile interpretation; then the infertility work-up for both partners.

  4. Day 4: Menopause, MHT choices and contraindications, POI and premenstrual disorders.

  5. Day 5: Prolapse, incontinence, ovarian cysts, torsion and Bartholin abscess.

  6. Day 6: 35 mixed gynaecology questions under time; rewrite the table from memory and redo the flashcards.

Practise gynaecology free

Gynaecology: questions candidates ask

How much gynaecology is in the AMC MCQ?

The AMC lists women's health as one of the exam's clinical areas, and gynaecology is a substantial part of it. The AMC does not publish an exact count per topic, so prepare the common primary care presentations thoroughly.

Do I need to know surgical procedures in detail?

No. Know the indications for referral and surgery, and the first-line medical treatments. Questions focus on investigation and initial management.

Is AMH used to diagnose PCOS in Australia?

Under the 2023 international guideline, AMH can be used instead of ultrasound for the ovarian criterion in adults, but not in adolescents within eight years of menarche.

When is MHT contraindicated?

Current or past breast cancer, undiagnosed vaginal bleeding, active liver disease, and recent VTE or stroke are key contraindications. Many other conditions are managed by choosing a transdermal route.

What is the first test for amenorrhoea?

A pregnancy test, every time. Then FSH, LH, oestradiol, prolactin and TSH guide the diagnosis.

Practise gynaecology until the decisions are automatic

Free account, 50 questions, full explanations. Upgrade only if it helps.